[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1485 Introduced in House (IH)]

<DOC>






118th CONGRESS
  1st Session
                                H. R. 1485

        To limit the price charged by manufacturers for insulin.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             March 9, 2023

Ms. Bush (for herself, Ms. Clarke of New York, Ms. Garcia of Texas, Ms. 
 Tlaib, Ms. Ocasio-Cortez, Ms. Norton, Mr. Bowman, Mr. Green of Texas, 
  Ms. Pressley, Mr. Garcia of Illinois, Ms. Jayapal, Mr. Khanna, Mr. 
Payne, and Ms. Omar) introduced the following bill; which was referred 
                to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
        To limit the price charged by manufacturers for insulin.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Insulin for All Act of 2023''.

SEC. 2. LIMITATION ON PRICE OF INSULIN.

    (a) In General.--Notwithstanding any other provision of law, the 
price charged by manufacturers of insulin for insulin that is sold in 
the United States may not exceed $20 per 1000 units of insulin, which 
may be contained in one or more vials, pens, cartridges, or other forms 
of delivery.
    (b) Insulin Defined.--In this section, the term ``insulin'' means 
insulin that is licensed under subsection (a) or (k) of section 351 of 
the Public Health Service Act (42 U.S.C. 262) and continues to be 
marketed pursuant to such licensure.
                                 <all>